Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: A meta-analysis
International Journal of Rheumatic Diseases | Sep 04, 2017
Sun C, et al. – The objective of this analysis was to assess prevalence and risk of metabolic syndrome (MetS) in patients with systemic lupus erythematosus (SLE). Collected data represented that the prevalence of MetS in patients with SLE was 26%. An increased risk of developing MetS was reported in patients with SLE than the control population.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
